Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats
Myocardial bioavailability of ANP is a major determinant of peptide efficacy in reducing cardiac fibrosis and improving pump function during diabetic cardiomyopathy.
Authors
- Elise Balse (ORCID: https://orcid.org/0000-0001-5224-9180)
- Stéphane Hatem (ORCID: https://orcid.org/0000-0002-9790-0755)
- Youakim Saliba (ORCID: https://orcid.org/0000-0001-8093-2593)
- Nassim Farès (ORCID: https://orcid.org/0000-0002-2935-2611)
- Guy Achkouty (ORCID: https://orcid.org/0000-0002-7101-5686)
- Joelle Hajal
- Albert Semaan (ORCID: https://orcid.org/0000-0001-8915-5970)
- Nadine Suffee (ORCID: https://orcid.org/0000-0001-9277-5089)
- Hrag Oskaridjian
- Miguel Albuquerque (ORCID: https://orcid.org/0000-0001-7311-1623)
- Chloé Azevedo
- Jules Joel Bakhos
Institutions
- Inserm (FR)
- Saint Joseph University (LB)
- Université Paris Cité (FR)
- Hôpital Beaujon (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- Centre de Recherche sur l'Inflammation (FR)
- Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/ehjopen/oeaf031
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05